Showing results (91-100 of 245) with videos related to
Sort By:
Pageof 25
Nature|September 6, 2016
On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer modelsHyejin Cho, Xinlin Du, James P Rizzi, et al.Nature Medicine|January 9, 2018
Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanismsMarco Bezzi, Nina Seitzer, Tomoki Ishikawa, et al.JAMA Oncology|May 30, 2020
Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma: The SAVOIR Phase 3 Randomized Clinical TrialToni K Choueiri, Daniel Y C Heng, Jae Lyun Lee, et al.BMC Cancer|August 8, 2021
Outcomes based on plasma biomarkers in METEOR, a randomized phase 3 trial of cabozantinib vs everolimus in advanced renal cell carcinomaThomas Powles, Toni K Choueiri, Robert J Motzer, et al.Urologic Oncology|March 15, 2011
RET protein expression in papillary renal cell carcinomaRichard Flavin, Stephen P Finn, Toni K Choueiri, et al.Molecular Cancer Research : MCR|September 4, 2014
RNA-seq reveals aurora kinase-driven mTOR pathway activation in patients with sarcomatoid metastatic renal cell carcinomaSumanta K Pal, Miaoling He, Tommy Tong, et al.European Urology|April 18, 2017
Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell CarcinomaSumanta K Pal, Guru Sonpavde, Neeraj Agarwal, et al.Clinical Genitourinary Cancer|May 15, 2018
Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell CarcinomaXin Gao, Opeyemi Jegede, Connor Gray, et al.European Urology|June 26, 2012
BRAF mutations in metanephric adenoma of the kidneyToni K Choueiri, John Cheville, Emanuele Palescandolo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2013
The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinomaToni K Choueiri, André P Fay, Robert Gagnon, et al.Pageof 25